학술논문

Rapid Improvement after Starting Elexacaftor-Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and Advanced Pulmonary Disease.
Document Type
journal article
Source
American Journal of Respiratory & Critical Care Medicine; 7/1/2021, Vol. 204 Issue 1, p64-73, 10p
Subject
CYSTIC fibrosis treatment
CYSTIC fibrosis transmembrane conductance regulator
DRUG efficacy
LUNG transplantation
TREATMENT of respiratory diseases
LAXATIVES
PYRIDINE
QUINOLINE
RESEARCH
COMBINATION drug therapy
INDOLE compounds
PHENOLS
BIOLOGICAL transport
LUNG diseases
HETEROCYCLIC compounds
RESEARCH methodology
MEDICAL cooperation
EVALUATION research
CYSTIC fibrosis
COMPARATIVE studies
LONGITUDINAL method
Language
ISSN
1073449X
Abstract
Copyright of American Journal of Respiratory & Critical Care Medicine is the property of American Thoracic Society and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)